Literature DB >> 12368970

A comparison of two versus one blood culture in the diagnosis and treatment of coagulase-negative staphylococcus in the neonatal intensive care unit.

Simon Struthers1, Helen Underhill, Susan Albersheim, David Greenberg, Simon Dobson.   

Abstract

OBJECTIVES: This study compares two versus one blood culture in the diagnosis and treatment of coagulase-negative staphylococcus (CONS) in babies with suspected sepsis. STUDY
DESIGN: The study was performed at British Columbia's Children's Hospital Neonatal Intensive Care Unit between March 1999 to March 2000. One hundred pairs of cultures were drawn from two percutaneous sites from babies more than 48 hours old at the time of a sepsis screen. CONS cultured from both sites was regarded as evidence of infection. Positive culture from only one of the two sites was regarded as contaminant. The difference in rates of diagnosed CONS infection and reduction in antibiotic usage when using two versus one blood culture was calculated.
RESULTS: In 5% of babies, cultures from a second site did not substantiate the diagnosis of CONS when compared to the result from a single culture. The resultant reduction in antibiotic use was 8.2%.
CONCLUSIONS: Two blood cultures reduce the number of children diagnosed with CONS infection and reduce antibiotic usage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368970     DOI: 10.1038/sj.jp.7210792

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  11 in total

1.  Clinical and Microbiologic Characteristics of Early-onset Sepsis Among Very Low Birth Weight Infants: Opportunities for Antibiotic Stewardship.

Authors:  Sagori Mukhopadhyay; Karen M Puopolo
Journal:  Pediatr Infect Dis J       Date:  2017-05       Impact factor: 2.129

2.  Persistent coagulase-negative staphylococci bacteremia in very-low-birth-weight infants.

Authors:  Nehama Linder; Adriana Hernandez; Limor Amit; Gil Klinger; Shai Ashkenazi; Itzhak Levy
Journal:  Eur J Pediatr       Date:  2011-01-08       Impact factor: 3.183

Review 3.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  Optimizing the Use of Antibacterial Agents in the Neonatal Period.

Authors:  Joseph B Cantey
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

5.  Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.

Authors:  Nehama Linder; Daniel Lubin; Adriana Hernandez; Limor Amit; Shai Ashkenazi
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

6.  Coagulase-negative staphylococcal infections in a neonatal intensive care unit: In vivo response to cloxacillin.

Authors:  Marc P Blayney; Mahmud Al Madani
Journal:  Paediatr Child Health       Date:  2006-12       Impact factor: 2.253

7.  Comparative microbial analysis of paired amniotic fluid and cord blood from pregnancies complicated by preterm birth and early-onset neonatal sepsis.

Authors:  Xiaowei Wang; Catalin S Buhimschi; Stephanie Temoin; Vineet Bhandari; Yiping W Han; Irina A Buhimschi
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  Variations in rates of nosocomial infection among Canadian neonatal intensive care units may be practice-related.

Authors:  Khalid Aziz; Douglas D McMillan; Wayne Andrews; Margaret Pendray; Zhenguo Qiu; Stella Karuri; Shoo K Lee
Journal:  BMC Pediatr       Date:  2005-07-08       Impact factor: 2.125

9.  Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study.

Authors:  Sarah L Lawrence; Virginia Roth; Robert Slinger; Baldwin Toye; Isabelle Gaboury; Brigitte Lemyre
Journal:  BMC Pediatr       Date:  2005-12-23       Impact factor: 2.125

10.  Sustainable neonatal CLABSI surveillance: consensus towards new criteria in the Netherlands.

Authors:  I E Heijting; T A J Antonius; A Tostmann; W P de Boode; M Hogeveen; J Hopman
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-05       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.